Back to All

Diaceutics are finalists in the 2021 Fierce Healthcare Innovation Awards

2 November, 2021

Featured

Diaceutics are finalists in the Data Analytics/Business Intelligence category at the Fierce Healthcare Innovation Awards 2021. The awards are organised by the publisher of Fierce Healthcare and will identify and showcase companies with outstanding innovation who are driving improvements and transforming the healthcare industry. 

The expert panel of judges will determine which companies demonstrate innovative solutions that have the greatest potential to save money, engage patients, or revolutionize the industry. The winners will be announced in a special Innovation Report in December. Diaceutics’ entries focus on the application of machine learning and AI to identify the best possible testing journey for patients using DDPs® (Diagnostic Deductive Pathways) enabled by DXRX – The Diagnostic Network®. DXRX is the world’s first diagnostic commercialisation platform for precision medicine, integrating multiple pipelines of real-world diagnostic testing data from a global network of laboratories 

Commenting on the news, Sarah Colgan, Director of Global Marketing at Diaceutics said, “We are honoured to have been shortlisted in the Data Analytics/Business Intelligence category. Since launching our DXRX platform just 12 months ago, our ability to harmonize multiple global pipelines of complex diagnostic testing data into actionable commercial insights for our pharmaceutical customers has rapidly accelerated, which is great news for the industry and most importantly, for patients. We thank Fierce Healthcare for celebrating the value of our Deductive Diagnostic Pathways (DDPs®) in getting more patients access to the right treatment at the right time.” 

Diaceutics has been shortlisted alongside Codoxo's  Forensic AI Platform, Healthcare's Data Science Platform ClosedLoop and Hospital IQ Operations Management Platform. 

Request a Demo now to find out more about DXRX  The Diagnostic Network® DXRX Data - Diaceutics 

 

About Diaceutics

At Diaceutics we believe that every patient should get the precision medicine they deserve. We are a data analytics and end-to-end services provider enabled by DXRX - the world’s first Network solution for the development and commercialization of precision medicine diagnostics. 

Diaceutics has worked on every precision medicine brought to market and provides services to 36 of the world’s leading pharmaceutical companies. We have built the world’s largest repository of diagnostic testing data with a growing network of 2500 labs in 51 countries.

Public Relations & Investor Relations advisers

Alma PR
71-73 Carter Lane
London
EC4V 5EQ.

Tel: +44 (0)20 3405 0205 or [email protected]


 
Caroline Forde
Robyn Fisher
 
Kieran Breheny